Live Cell Imaging Market by Product , Technology & by Application - Analysis & Global Forecast to 2019

Over the years, the live cell imaging market has witnessed various technological advancements in order to study the functions of live cells that meet the needs of academic and government institutes, pharmaceutical and biotechnology industries, contract research organizations, and diagnostics laboratories. These advancements have led to the development of various technologies used for live cell imaging.

In 2014, the equipment segment accounted for the largest share of the live cell imaging market, by product; the microscopy segment accounted for the largest share of the live cell imaging market, by equipment; the assay kits segment accounted for the largest share of the live cell imaging market, by consumables; the fluorescence resonance energy transfer (FRET) segment accounted for the largest share of the live cell imaging market, by technology; and the cell biology segment accounted for the largest share of live cell imaging market, by application.

In 2014, North America accounted for the largest share of the live cell imaging market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the live cell imaging market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of equipment, consumables, and software involved in live cell imaging.

The global live cell imaging market witnesses high-competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographical expansions, and acquisitions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on the product portfolios offered by the top players in the live cell imaging market. The report analyzes the live cell imaging market by product, technology, and application

‧ Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the live cell imaging market

‧ Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various live cell imaging technologies across regions

‧ Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the live cell imaging market

‧ Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the live cell imaging market

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 21
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 23
2.1.1 SECONDARY RESEARCH 23
2.1.1.1 Key data from secondary sources 23
2.1.2 PRIMARY RESEARCH 24
2.1.3 KEY INDUSTRY INSIGHTS 25
2.1.3.1 Key data from primary sources 26
2.1.3.2 Key Insights from primary sources 26
2.2 MARKET SIZE ESTIMATION METHODOLOGY 27
2.3 MARKET FORECAST METHODOLOGY 29
2.4 MARKET DATA VALIDATION AND DATA TRIANGULATION 30
2.5 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
3.1 INTRODUCTION 31
3.2 MARKET DYNAMICS 31
3.2.1 LIVE CELL IMAGING MARKET, BY PRODUCT 31
3.2.2 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE 32
3.2.3 LIVE CELL IMAGING MICROSCOPY MARKET, BY TYPE 33
3.2.4 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE 34
3.2.5 LIVE CELL IMAGING MARKET, BY TECHNOLOGY 35
3.2.6 LIVE CELL IMAGING MARKET, BY APPLICATION 35
3.2.7 LIVE CELL IMAGING MARKET, BY REGION 36
3.3 MARKET SHARE 37
3.4 COMPETITIVE LANDSCAPE 37
3.5 KEY PLAYERS 37
?
4 PREMIUM INSIGHTS 38
4.1 GLOBAL LIVE CELL IMAGING MARKET SIZE 38
4.2 GLOBAL LIVE CELL IMAGING MARKET, BY PRODUCT 39
4.3 LIVE CELL IMAGING MARKET, BY APPLICATION AND REGION 39
4.4 LIVE CELL IMAGING MICROSCOPES MARKET, BY TYPE 40
4.5 REGIONAL SNAPSHOT 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET SEGMENTATION 42
5.3 MARKET DYNAMICS 43
5.3.1 DRIVERS 43
5.3.1.1 Adoption of high-content screening techniques in drug discovery 43
5.3.1.2 Rising incidences of cancer 44
5.3.1.3 Government funding for cell-based research 44
5.3.2 RESTRAINTS 45
5.3.2.1 High cost of high-content screening systems 45
5.3.2.2 Shortage of skilled professionals 45
5.3.3 CHALLENGE 46
5.3.3.1 Maintaining cell viability & cellular environment in the culture 46
5.3.4 OPPORTUNITIES 47
5.3.4.1 Asian market presents high-growth opportunities 47
5.3.4.2 Adoption of HCS for primary screening 47
5.3.4.3 Application of live cell imaging techniques in personalized medicine 47
6 INDUSTRY TRENDS 49
6.1 END-USER MARKET POTENTIAL ANALYSIS 49
6.1.1 ACADEMIC AND GOVERNMENT INSTITUTES 49
6.1.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 50
6.1.3 CONTRACT RESEARCH ORGANIZATIONS (CRO) 50
6.1.4 DIAGNOSTIC LABORATORIES 50
6.2 SUPPLY CHAIN ANALYSIS 51
6.2.1 PROMINENT COMPANIES 51
6.2.2 SMALL AND MEDIUM ENTERPRISES 52
6.2.3 END USERS 52
6.2.4 KEY INFLUENCERS 52
7 MARKET POTENTIAL ANALYSIS 53
7.1 INTRODUCTION 53
7.2 UNMET NEEDS/LIMITING FACTORS 53
7.3 WINNING IMPERATIVES TO BOOST THE ADOPTION OF LIVE CELL IMAGING TECHNIQUES 54
8 LIVE CELL IMAGING MARKET, BY PRODUCT 56
8.1 INTRODUCTION 57
8.2 INSTRUMENTS 59
8.2.1 STANDALONE SYSTEMS 60
8.2.2 MICROSCOPES 61
8.2.2.1 Conventional microscopes 62
8.2.2.2 Confocal microscopes 63
8.2.2.3 Advanced fluorescence microscopes 64
8.2.3 CELL ANALYZERS 65
8.2.4 IMAGE CAPTURING DEVICES 65
8.3 CONSUMABLES 66
8.3.1 ASSAY KITS 67
8.3.2 REAGENTS 68
8.3.3 MEDIA 69
8.3.4 OTHER CONSUMABLES 70
8.4 SOFTWARE 71
9 LIVE CELL IMAGING MARKET, BY TECHNOLOGY 72
9.1 INTRODUCTION 73
9.2 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) 76
9.3 FLUORESCENCE IN SITU HYBRIDIZATION (FISH) 77
9.4 HIGH-CONTENT SCREENING (HCS) 78
9.5 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP) 79
9.6 RATIOMETRIC IMAGING 80
9.7 TOTAL INTERNAL REFLECTION FLUORESCENCE MICROSCOPY (TIRF) 81
9.8 MULTIPHOTON EXCITATION MICROSCOPY (MPE) 82
9.9 OTHER TECHNOLOGIES 83
10 LIVE CELL IMAGING MARKET, BY APPLICATION 84
10.1 INTRODUCTION 85
10.2 CELL BIOLOGY 88
10.3 STEM CELLS 89
10.4 DEVELOPMENTAL BIOLOGY 90
10.5 DRUG DISCOVERY 91
11 LIVE CELL IMAGING MARKET, BY REGION 92
11.1 INTRODUCTION 93
11.2 NORTH AMERICA 95
11.2.1 U.S. 99
11.2.1.1 Increasing incidences of cancer 99
11.2.1.2 Growth in pharmaceutical & biotechnology industries in the U.S. 99
11.2.1.3 High-content screening (HCS) conferences in the U.S. 99
11.2.2 CANADA 103
11.2.2.1 Increasing investments by the Canadian Government on regenerative medicine 103
11.2.2.2 Drug discovery research in Canada 103
11.3 EUROPE 107
11.3.1.1 Increasing government funding in Europe 108
11.3.2 U.K. 111
11.3.2.1 Conferences on live cell imaging 111
11.3.3 GERMANY 114
11.3.3.1 Advancements in biotechnology 114
11.3.4 FRANCE 117
11.3.4.1 Advancements in the biotechnology sector 117
11.3.5 REST OF EUROPE (ROE) 120
11.3.5.1 Increasing research on regenerative medicine in Spain 120
11.4 ASIA 123
11.4.1 INDIA 126
11.4.1.1 Growing pharmaceutical industry 126
11.4.2 CHINA 129
11.4.2.1 Rising burden of cancer in China 129
11.4.2.2 Developing pharmaceutical industry in China 129
11.4.2.3 Increasing government investments in the life sciences sector in China 129
11.4.2.4 Conferences on live cell imaging in China 130
11.4.3 JAPAN 133
11.4.3.1 Growing focus on stem cell research in Japan 133
11.4.3.2 Regenerative medicine and biomedical and medical research set to trigger growth 133
11.4.4 REST OF ASIA (ROA) 136
11.4.4.1 Increasing government support for strong academic and commercial R&D activities in Taiwan 136
11.5 REST OF THE WORLD (ROW) 139
11.5.1 FLOURISHING BIOTECHNOLOGY AND PHARMACEUTICAL MARKETS IN BRAZIL 139
11.5.2 SIGNIFICANT DEVELOPMENTS IN THE PHARMACEUTICAL MARKET IN AFRICA 140
12 COMPETITIVE LANDSCAPE 143
12.1 MARKET SHARE ANALYSIS, LIVE CELL IMAGING MARKET 143
12.1.1 INTRODUCTION 143
12.1.2 CARL ZEISS AG 144
12.1.3 NIKON CORPORATION 144
12.1.4 LEICA MICROSYSTEMS (ACQUIRED BY DANAHER CORPORATION) 145
12.2 COMPETITIVE SITUATION AND TRENDS 146
12.2.1 INTRODUCTION 146
12.2.2 NEW PRODUCT LAUNCHES 147
12.2.3 AGREEMENTS,PARTNERSHIPS, ALLIANCE AND COLLABORATIONS 148
12.2.4 EXPANSIONS 149
12.2.5 ACQUISITIONS 150
12.2.6 OTHERS 151
13 COMPANY PROFILES 152
(Overview, Financials, Products & Services, Strategy, & Developments)*
13.1 INTRODUCTION 152
13.2 BECTON, DICKINSON AND COMPANY 153
13.3 CARL ZEISS AG 156
13.4 DANAHER CORPORATION (LEICA MICROSYSTEMS) 159
13.5 GE HEALTHCARE (SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 162
13.6 MOLECULAR DEVICES, LLC 165
13.7 NIKON CORPORATION 167
13.8 OLYMPUS CORPORATION 170
13.9 PERKINELMER, INC. 173
13.10 SIGMA-ALDRICH CORPORATION 176
13.11 THERMO FISHER SCIENTIFIC, INC. 179
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
14 APPENDIX 182
14.1 DISCUSSION GUIDE 182
14.2 COMPANY DEVELOPMENTS (2012–2015) 186
14.2.1 CARL ZEISS AG 186
14.2.2 DANAHER CORPORATION (2012-2014) 187
14.2.3 NIKON CORPORATION (2012-2014) 188
14.2.4 PERKINELMER, INC. (2012) 188
14.2.5 SIGMA-ALDRICH CORPORATION (2012-2014) 189
14.2.6 THERMO FISHER SCIENTIFIC, INC. (2012-2014) 190
14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 191
14.4 AVAILABLE CUSTOMIZATIONS 191
14.5 RELATED REPORTS 192